PMDA drug package insert
エスラックス静注25mg/2.5mL
PMDA Prescription drug · MSD株式会社 · package insert Mar 28, 2024
Key facts
| Brand names | エスラックス静注25mg/2.5mL, エスラックス静注50mg/5.0mL |
|---|---|
| Nonproprietary names | ロクロニウム臭化物 |
| Companies | 製造販売元／MSD株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 非脱分極性麻酔用筋弛緩剤 |
| Therapeutic category codes | 871229 |
| YJ codes | 1229405A1028, 1229405A2024 |
| Approval numbers | 21900AMX01134000, 21900AMX01135000 |
| Package insert edition | 第2版 |
| Package insert date | Mar 28, 2024 |
| PMDA document key | 170050_1229405A1028_2 |
| PMDA company code | 170050 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: